unknown
Stage
3
Investors
About
Candid Therapeutics develops treatments targeting autoimmune diseases to revolutionize therapeutic approaches in this medical area.
Explore Candid Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.